$4.26
-0.105[-2.41%]
At close: May 20
$4.26
0[0.00%]
After Hours: 4:00PM EDT
Macrogenics
(NASDAQ:MGNX)Macrogenics Stock (NASDAQ:MGNX), Quotes and News Summary
Macrogenics Stock (NASDAQ: MGNX) stock price, news, charts, stock research, profile.
| Open | $4.420 |
| Close | - |
| Volume / Avg. | 2.106M / 2.479M |
| Day Range | 4.090 - 4.430 |
| 52 Wk Range | 3.140 - 21.880 |
| Market Cap | $266.819M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 23 |
| Short Interest | 19.53% |
| Days to Cover | 13.42 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Macrogenics (MGNX) stock?
You can purchase shares of Macrogenics (NASDAQ: MGNX) through any online brokerage.
Who are Macrogenics's (MGNX) competitors?
Other companies in Macrogenics’s space includes: Inozyme Pharma (NASDAQ:INZY), Adaptimmune Therapeutics (NASDAQ:ADAP), Opthea (NASDAQ:OPT), Monte Rosa Therapeutics (NASDAQ:GLUE) and Century Therapeutics (NASDAQ:IPSC).
What is the target price for Macrogenics (MGNX) stock?
The latest price target for Macrogenics (NASDAQ: MGNX) was reported by HC Wainwright & Co. on Monday, May 13, 2024. The analyst firm set a price target for 4.00 expecting MGNX to fall to within 12 months (a possible -6.10% downside). 23 analyst firms have reported ratings in the last year.
Current Stock Price for Macrogenics (MGNX)?
The stock price for Macrogenics (NASDAQ: MGNX) is $4.26 last updated Today at May 20, 2024 at 4:00 PM EDT.
Does Macrogenics (MGNX) pay a dividend?
There are no upcoming dividends for Macrogenics.
When is Macrogenics (NASDAQ:MGNX) reporting earnings?
Macrogenics’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
Is Macrogenics (MGNX) going to split?
There is no upcoming split for Macrogenics.
What sector and industry does Macrogenics (MGNX) operate in?
Macrogenics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.